Medecine Development for Global Health
Project Team
The project team at Medicine Development for Global Health (MDGH) brings together diverse expertise in biomedical research, clinical development, and public health innovation to advance equitable access to essential medicines worldwide. Committed to addressing the needs of underserved populations, this interdisciplinary team contributes to sustainable health solutions through collaborative scientific partnerships and community-focused initiatives.
Achievements
Medicine Development for Global Health (MDGH) has significantly advanced global health through its development and delivery of affordable, high-quality medicines for neglected diseases. Its work supports international strategies to address critical health challenges affecting underserved populations. Through strong global partnerships, MDGH fosters innovative approaches to ensure equitable access to essential treatments. Its commitment to sustainable development and capacity building ensures a lasting impact in the countries it serves.
Main contact person
Medicine Development for Global Health (MDGH) is an independent, not-for-profit organisation dedicated to developing and delivering affordable, high-quality medicines that address urgent global health needs. Focused on diseases such as onchocerciasis, tuberculosis, and other neglected conditions, MDGH contributes to advancing equitable access to essential treatments through innovative partnerships and rigorous clinical development.
Mark Sullivan, Founder and Managing Director of MDGH, serves as the principal contact for the EMINENCE project, overseeing the organisation’s scientific contributions and strategic engagement within the consortium.
About Us
The EMINENCE project is dedicated to eliminating onchocerciasis in Africa through innovative clinical research and the evaluation of moxidectin to enhance disease control and accelerate eradication efforts.
Useful Links:
Social Media
© EMINENCE - EDCTP. All rights reserved